Outcomes in Critically Ill Allogeneic Hematopoietic Stem-Cell Transplantation Recipients.
Antoine LafargeThibault DupontEmmanuel CanetAnne-Sophie MoreauMuriel PicardDjamel MokartLaura PlatonJulien MayauxFlorent WalletNahema IssaJean-Herlé RaphalenFrédéric PèneAnne RenaultRégis Peffault de la TourChristian RécherPatrice ChevallierLara ZafraniMichael DarmonNaike BigéElie AzoulayPublished in: American journal of respiratory and critical care medicine (2024)
Most critically ill Allo-HSCT recipients survive their ICU stay, including those requiring mechanical ventilation, with an overall day-90 survival rate reaching 51.8%. A careful assessment of goals of care is required in patients with ≥ 2 risk factors for mortality.
Keyphrases
- mechanical ventilation
- allogeneic hematopoietic stem cell transplantation
- intensive care unit
- acute respiratory distress syndrome
- acute lymphoblastic leukemia
- acute myeloid leukemia
- kidney transplantation
- healthcare
- respiratory failure
- palliative care
- cardiovascular events
- quality improvement
- extracorporeal membrane oxygenation
- free survival
- cardiovascular disease
- global health
- adipose tissue
- metabolic syndrome
- health insurance